BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Tumor markers
1
Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer
11/25/2022 9:29:01 AM | Browse: 201 | Download: 447
2
Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives
7/18/2022 9:47:46 AM | Browse: 304 | Download: 549
3
Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma
1/11/2022 8:34:26 AM | Browse: 346 | Download: 675
4
Giant simple hepatic cyst with multiple elevated serum tumor markers: A case report
12/21/2020 12:21:52 PM | Browse: 507 | Download: 1129
5
Real impact of tumor marker AFP and PIVKA-Ⅱ in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
11/24/2020 12:41:21 PM | Browse: 450 | Download: 881
6
Leveraging machine learning techniques for predicting pancreatic neuroendocrine tumors grade using biochemical and tumor markers
7/6/2019 11:29:12 AM | Browse: 731 | Download: 1077
7
Biomarkers in colorectal cancer: Current clinical utility and future perspectives
12/6/2018 1:35:44 PM | Browse: 825 | Download: 914
8
Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
3/24/2017 9:18:00 AM | Browse: 1138 | Download: 1988
9
Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma
9/16/2014 3:23:00 PM | Browse: 1060 | Download: 901
10
Elevated serum levels of human relaxin-2 in patients with esophageal squamous cell carcinoma
9/16/2014 1:19:00 PM | Browse: 861 | Download: 780